CCL2 and breast cancer: As an example of the paradoxical effect of CCL2, it has been reported that interruption of CCL2 inhibition accelerates breast cancer metastasis through angiogenesis, and that anti-IL-6 treatment after interruption of anti-CCL2 therapy can prevent lung metastases [100].